Status:
ACTIVE_NOT_RECRUITING
Structured Peer-delivered ART and Reentry Community Strategy
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Aurum Institute
Seoul National University
Conditions:
Retention in Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overarching goal of this study is to implement both a transition community adherence club strategy (Group-SPARCS) and an ART provision strategy (ART-SPARCS) for HIV-positive individuals transition...
Detailed Description
Background: The South African government has devoted resources towards HIV care in correctional facilities that have resulted in antiretroviral therapy (ART) coverage of \>90% and viral load (VL) supp...
Eligibility Criteria
Inclusion
- Incarcerated at one of the participating study enrolment sites, awaiting trial (un-sentenced) and sentenced individuals.
- Diagnosed with HIV and ART at the time of enrolment.
- Anticipated release or trial date within three months of study enrolment.
- Self-report expected to reside in an unrestricted environment within Ekurhuleni, Tshwane, or Johannesburg districts of Gauteng Province and within proximity to one of the SPARCS intervention sites (i.e., within 20km, 45-minute travel time, or two local taxi minibus rides)
- Willing to participate in study post-release follow-up activities and provide contact information for post-release follow-up.
Exclusion
- \<18 years of age.
- Condition (severe cognitive dysfunction or mental illness) rendering the individual unable to provide informed consent.
- Unable to provide informed consent to participate in the study.
- Assessment by DCS health staff indicating that the individual requires a high intensity of care exceeding that which can be provided in a differentiated model of care setting.
- Not released from the correctional facility during the period of intervention delivery.
- Release to a region outside of Gauteng.
Key Trial Info
Start Date :
November 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2028
Estimated Enrollment :
640 Patients enrolled
Trial Details
Trial ID
NCT06027671
Start Date
November 18 2024
End Date
July 31 2028
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Aurum Institute - Head office
Johannesburg, Gauteng, South Africa, 2193